The unfolded protein response in neurodegenerative diseases: a neuropathological perspective

被引:289
作者
Scheper, Wiep [1 ,2 ,3 ,4 ]
Hoozemans, Jeroen J. M. [5 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Alzheimer Ctr, NL-1007 MB Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genome Anal & Mol & Cellular Neurosci, NL-1007 MB Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
关键词
ER stress; Unfolded protein response; PERK; eIF2alpha; Neuropathology; Neurodegeneration; ENDOPLASMIC-RETICULUM STRESS; AMYOTROPHIC-LATERAL-SCLEROSIS; EUKARYOTIC INITIATION FACTOR-2-ALPHA; GLUCOSE-REGULATED PROTEINS; TRANSCRIPTION FACTOR XBP-1; MOTOR-NEURON DEGENERATION; ALZHEIMERS-DISEASE; ER STRESS; GRANULOVACUOLAR DEGENERATION; MESSENGER-RNA;
D O I
10.1007/s00401-015-1462-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The unfolded protein response (UPR) is a stress response of the endoplasmic reticulum (ER) to a disturbance in protein folding. The so-called ER stress sensors PERK, IRE1 and ATF6 play a central role in the initiation and regulation of the UPR. The accumulation of misfolded and aggregated proteins is a common characteristic of neurodegenerative diseases. With the discovery of the basic machinery of the UPR, the idea was born that the UPR or part of its machinery could be involved in neurodegenerative diseases like Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and prion disease. Over the last decade, the UPR has been addressed in an increasing number of studies on neurodegeneration. The involvement of the UPR has been investigated in human neuropathology across different neurological diseases, as well as in cell and mouse models for neurodegeneration. Studies using different disease models display discrepancies on the role and function of the UPR during neurodegeneration, which can often be attributed to differences in methodology. In this review, we will address the importance of investigation of human brain material for the interpretation of the role of the UPR in neurological diseases. We will discuss evidence for UPR activation in neurodegenerative diseases, and the methodology to study UPR activation and its connection to brain pathology will be addressed. More recently, the UPR is recognized as a target for drug therapy for treatment and prevention of neurodegeneration, by inhibiting the function of specific mediators of the UPR. Several preclinical studies have shown a proof-of-concept for this approach targeting the machinery of UPR, in particular the PERK pathway, in different models for neurodegeneration and have yielded paradoxical results. The promises held by these observations will need further support by clarification of the observed differences between disease models, as well as increased insight obtained from human neuropathology.
引用
收藏
页码:315 / 331
页数:17
相关论文
共 130 条
[1]   Tau Accumulation Activates the Unfolded Protein Response by Impairing Endoplasmic Reticulum-Associated Degradation [J].
Abisambra, Jose F. ;
Jinwal, Umesh K. ;
Blair, Laura J. ;
O'Leary, John C., III ;
Li, Qingyou ;
Brady, Sarah ;
Wang, Li ;
Guidi, Chantal E. ;
Zhang, Bo ;
Nordhues, Bryce A. ;
Cockman, Matthew ;
Suntharalingham, Amirthaa ;
Li, Pengfei ;
Jin, Ying ;
Atkins, Christopher A. ;
Dickey, Chad A. .
JOURNAL OF NEUROSCIENCE, 2013, 33 (22) :9498-9507
[2]   RETRACTED: Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis (Retracted Article) [J].
Atkin, Julie D. ;
Farg, Manal A. ;
Walker, Adam K. ;
McLean, Catriona ;
Tomas, Doris ;
Horne, Malcolm K. .
NEUROBIOLOGY OF DISEASE, 2008, 30 (03) :400-407
[3]   Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) [J].
Axten, Jeffrey M. ;
Medina, Jesus R. ;
Feng, Yanhong ;
Shu, Arthur ;
Romeril, Stuart P. ;
Grant, Seth W. ;
Li, William Hoi Hong ;
Heerding, Dirk A. ;
Minthorn, Elisabeth ;
Mencken, Thomas ;
Atkins, Charity ;
Liu, Qi ;
Rabindran, Sridhar ;
Kumar, Rakesh ;
Hong, Xuan ;
Goetz, Aaron ;
Stanley, Thomas ;
Taylor, J. David ;
Sigethy, Scott D. ;
Tomberlin, Ginger H. ;
Hassell, Annie M. ;
Kahler, Kirsten M. ;
Shewchuk, Lisa M. ;
Gampe, Robert T. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (16) :7193-7207
[4]   GRANULOVACUOLAR DEGENERATION IN AGING BRAIN AND IN DEMENTIA [J].
BALL, MJ ;
LO, P .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1977, 36 (03) :474-487
[5]   Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response [J].
Bernales, Sebastian ;
McDonald, Kent L. ;
Walter, Peter .
PLOS BIOLOGY, 2006, 4 (12) :2311-2324
[6]   Selective autophagy of the endoplasmic reticulum [J].
Bernales, Sebastian ;
Schuck, Sebastian ;
Walter, Peter .
AUTOPHAGY, 2007, 3 (03) :285-287
[7]   A selective inhibitor-of eIF2α dephosphorylation protects cells from ER stress [J].
Boyce, M ;
Bryant, KF ;
Jousse, C ;
Long, K ;
Harding, HP ;
Scheuner, D ;
Kaufman, RJ ;
Ma, DW ;
Coen, DM ;
Ron, D ;
Yuan, JY .
SCIENCE, 2005, 307 (5711) :935-939
[8]   Staging of brain pathology related to sporadic Parkinson's disease [J].
Braak, H ;
Del Tredici, K ;
Rüb, U ;
de Vos, RAI ;
Steur, ENHJ ;
Braak, E .
NEUROBIOLOGY OF AGING, 2003, 24 (02) :197-211
[9]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[10]   Unraveling the mechanisms involved in motor neuron degeneration in ALS [J].
Bruijn, LI ;
Miller, TM ;
Cleveland, DW .
ANNUAL REVIEW OF NEUROSCIENCE, 2004, 27 :723-749